Is there a binding deficit in working memory in patients with schizophrenia? A meta-analysis.

Schizophr Res

Centre de recherche, Institut universitaire en santé mentale de Montréal, Montreal, Quebec, Canada; Department of Psychiatry, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada. Electronic address:

Published: September 2014

In schizophrenia (SZ), a specific binding deficit in working memory (WM) has not yet been demonstrated, given that studies with various methodologies were conducted and the results obtained were heterogeneous. Thus, a meta-analysis of 10 WM studies was performed. Effect sizes were calculated for binding and control conditions. Analyses disclosed significantly lower scores in SZ patients relative to controls for both binding and control conditions. In addition, analyses revealed no greater impairments for the binding condition than for the control condition in SZ patients. Our meta-analysis suggests that there is no specific deficit of binding in WM in SZ.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2014.06.012DOI Listing

Publication Analysis

Top Keywords

binding deficit
8
deficit working
8
working memory
8
binding control
8
control conditions
8
binding
6
memory patients
4
patients schizophrenia?
4
schizophrenia? meta-analysis
4
meta-analysis schizophrenia
4

Similar Publications

Dopamine receptor D4 (DRD4) plays a vital role in regulating various physiological functions, including attention, impulse control, and sleep, as well as being associated with various neurological diseases, including attention deficit hyperactivity disorder, novelty seeking, and so on. However, a comprehensive analysis of harmful nonsynonymous single nucleotide polymorphisms (nsSNPs) of the DRD4 gene and their effects remains unexplored. The aim of this study is to uncover novel damaging missense nsSNPs and their structural and functional effects on the DRD4 receptor.

View Article and Find Full Text PDF

Glutamate transporter activator LDN-212320 prevents chronic pain-induced cognitive impairment and anxiety-like behaviors in a mouse model.

Behav Brain Res

January 2025

Department of Pharmaceutical Sciences, College of Pharmacy, South Dakota State University, Brookings, SD 57007, USA. Electronic address:

The astroglial glutamate transporter in the hippocampus and anterior cingulate cortex (ACC) is critically involved in chronic pain-induced cognitive and psychiatric abnormalities. We have previously reported that LDN-212320, a glutamate transporter-1 (GLT-1) activator, attenuates complete Freund's adjuvant (CFA)-induced acute and chronic nociceptive pain. However, the cellular and molecular mechanisms underlying GLT-1 modulation in the hippocampus and ACC during chronic pain-induced cognitive deficit-like and anxiety-like behaviors remain unknown.

View Article and Find Full Text PDF

Effects of MeCP2 on chronic seizures and cognitive function in mice with temporal lobe epilepsy.

Epilepsy Res

January 2025

Institute of Neurobiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 West Yanta Road, Xi'an City 710061, China; Institute of Neuroscience, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, 76 West Yanta Road, Xi'an City 710061, China. Electronic address:

Mutations in methyl CpG binding protein 2 (MeCP2) are linked to Rett syndrome, in which epilepsy is one of the most well-described disorders. However, little is known about the specific role of MeCP2 during epileptogenesis. Our previous study has demonstrated that MeCP2 has a unique control on the development of mossy fiber sprouting (MFS) in the epileptic hippocampus.

View Article and Find Full Text PDF

Chlorpyrifos (CPF) is a broad-spectrum organophosphate insecticide. Long-term exposure to low levels of CPF is associated with neurodevelopmental and neurodegenerative disorders. The mechanisms leading to these effects are still not fully understood.

View Article and Find Full Text PDF

Background: Neuronal structure is disrupted after spinal cord injury (SCI), causing functional impairment. The effectiveness of exercise therapy (ET) in clinical settings for nerve remodeling post-SCI and its underlying mechanisms remain unclear. This study aims to explore the effects and related mechanisms of ET on nerve remodeling in SCI rats.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!